Conn syndrome, also known as primary hyperaldosteronism, is a condition of excess of aldosterone production and occurs secondary to adrenal cortical adenoma, bilateral adrenal hyperplasia, or rarely, adrenal carcinoma. Differentiation between the causes is required to avoid unnecessary surgery.
Conn syndrome typically presents with diastolic hypertension, metabolic alkalosis, and hypokalemia. Other symptoms include muscular weakness, paresthesias, headache, polyuria, and polydipsia. Edema is rare in these patients.
Primary hyperaldosteronism is distinguished from secondary hyperaldosteronism by measurement of serum renin:
- primary: low renin levels
- secondary: high renin levels
Conn syndrome is due to an autonomous solitary adrenal cortical adenoma in 65-70% of cases, with the remainder almost entirely due to bilateral adrenal hyperplasia (25-30%) with adrenal carcinoma being a rare cause.
Excess secretion of aldosterone can also occur in renin-related hypertension.
The aldosterone level tends to increase and the aldosterone-to-renin ratio is also increased.
The biochemical analysis may also demonstrate hypokalemia, which may be the first clue to the diagnosis of aldosteronoma in a patient being evaluated for hypertension. The baseline plasma aldosterone is usually greater than 20 g/dL.
Adrenal adenomas in Conn syndrome tend to be unilateral (95%) quite small, often ~2 cm (range 1-5 cm) in diameter, and can be a challenge to detect, even by CT or MR imaging.
Selective adrenal arteriography, venous sampling, adrenal phlebography, radionuclide studies and CT scans are helpful in diagnosis.
- aldosteronomas are homogeneous and often hypodense, with an attenuation value near that of water (<10 HU)
- none or minimal contrast enhancement
- rarely calcify
- detects 70% of aldosteronomas, although small lesions may be missed
- if CT findings are negative, selective adrenal venous sampling for aldosterone or a dexamethasone suppressed iodocholesterol adrenal scan may identify the lesion
Adrenal venous sampling to assay aldosterone serum via selective catheterization of both adrenal veins, may still only be helpful in ~50% of cases.
Treatment and prognosis
If a solitary adrenal mass is detected, surgical adrenalectomy will correct hypertension in 75-90% of cases. Bilateral adrenalectomy in patients with hyperplasia is not usually an effective treatment and results in adrenal insufficiency and is usually treated medically, making the differentiation between the etiologies necessary, to avoid unnecessary surgery.
History and etymology
It is named after Jerome W Conn (1907-1994), an American endocrinologist, who first described the condition in 1955 4.
- 1. Lingam RK, Sohaib SA, Vlahos I et-al. CT of primary hyperaldosteronism (Conn's syndrome): the value of measuring the adrenal gland. AJR Am J Roentgenol. 2003;181 (3): 843-9. AJR Am J Roentgenol (full text) - Pubmed citation
- 2. Sohaib SA, Peppercorn PD, Allan C et-al. Primary hyperaldosteronism (Conn syndrome): MR imaging findings. Radiology. 2000;214 (2): 527-31. Radiology (full text) - Pubmed citation
- 3. Patel SM, Lingam RK, Beaconsfield TI et-al. Role of radiology in the management of primary aldosteronism. Radiographics. 27 (4): 1145-57. doi:10.1148/rg.274065150 - Pubmed citation
- 4. Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 1955;45 (1): 3-17. - Pubmed citation
- 5. Grainger & Allison's Diagnostic Radiology: 2-Volume Set, 6e. Churchill Livingstone. ISBN:0702042951. Read it at Google Books - Find it at Amazon